Skip to content
MedBiz Pro

e-mail: info@medbizpro.com
  • News
  • Blog Zone
  • Contact
  • sr
MedBiz Pro > Vesti svet > Death by iron

Death by iron

Posted on 20/05/2019 by Mila

Source: Nature, Health Sciences, https://www.nature.com

Posted in Vesti svet
Post navigation
Walking and strength training may decrease the risk of dying from liver disease →
← Ultra-Processed foods delay satiety, increase food intake and weight gain

News

  • EpilepsyGTx raises $33 million Series A to develop single dose gene therapy for focal refractory epilepsy
    on 10/12/2025 at 1:00 pm

    EpilepsyGTx, a biotechnology company focused on research and development of cutting-edge gene therapies to treat refractory epilepsy, today announced it has raised $33 million in a Series A financing to advance its lead program EPY201 through Phase 1/2a clinical trials.

  • VALANX Biotech establishes Board of Directors
    on 10/12/2025 at 12:45 pm

    VALANX Biotech (VALANX), a biotech company developing novel antibody-drug-conjugate (ADC) assets enabled by its GoldenSite™ site-specific protein conjugation technology, today announced the formation of its Board of Directors.

  • Tec-Dara could represent a new standard of care for relapsed or refractory multiple myeloma
    on 10/12/2025 at 12:33 pm

    Patients with relapsed or refractory (R/R) multiple myeloma who received a combination of teclistamab, a bispecific monoclonal antibody, and daratumumab, a CD38-directed monoclonal antibody, were 83% more likely to be alive without disease progression compared with those who received standard second-line therapies at a median of nearly 35 months of follow-up, according to the results of a new trial presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition.

  • Pirtobrutinib shows superior outcomes compared to common first-line combination treatment for CLL/SLL
    on 10/12/2025 at 12:31 pm

    In a new trial, the Bruton tyrosine kinase (BTK) inhibitor pirtobrutinib increased the rate of survival without disease progression and was well tolerated with a more favorable safety profile when compared with bendamustine plus rituximab (BR) in patients with previously untreated chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).

  • Plan-switching, sign-up impersonations: Obamacare enrollment fraud persists
    on 10/12/2025 at 12:18 pm

    Florida resident Keith Jones says his Affordable Care Act insurance plan was changed multiple times this year without his permission. Now the 52-year-old is struggling with his health problems while facing large premium bills he says he shouldn't owe.

  • National study maps where food additives come from in children’s and adults’ diets
    on 10/12/2025 at 3:45 am

    By analysing nationally representative diet data, researchers show that food additives rarely occur alone, with children and teenagers experiencing the highest exposure to complex additive mixtures largely driven by ultra-processed foods.

  • Sterilized fermented beverage targets obesity and type 2 diabetes pathways in computational study
    on 10/12/2025 at 3:20 am

    Researchers profiled a terminally sterilized probiotic-fermented MFH beverage and identified aporphine alkaloids and flavonoids with favorable predicted ADMET properties. Integrated network pharmacology, molecular docking, and 100-ns MD simulations suggest multi-target engagement of metabolic-inflammatory pathways relevant to obesity and type 2 diabetes.

  • Researchers discover new biomarker of "complicated" mild- to severe-pediatric traumatic brain injury
    on 10/12/2025 at 2:18 am

    Researchers at the University of Pittsburgh and UPMC Children's Hospital of Pittsburgh discovered a promising new biomarker of "complicated" mild- to severe-pediatric traumatic brain injury, or TBI.

  • SIRT3 deficiency worsens eustachian tube dysfunction during middle-ear infection
    on 10/12/2025 at 2:12 am

    Middle-ear infections caused by Gram-negative bacteria remain among the most common pediatric illnesses worldwide.

  • New arts and wellbeing program supports the social needs of families affected by dementia
    on 10/12/2025 at 2:09 am

    A new arts and wellbeing program co-developed by the University of South Australia, Flinders University and the University of Adelaide shows that supporting the social needs of people living with dementia and their carers can help families rediscover connection, confidence and a sense of community.

  • Correction: Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer
    on 10/12/2025 at 12:00 am
  • Socioeconomic Factors, Comorbidities Tied to Late-Onset Depression in Long-Term Cancer Survivors
    on 09/12/2025 at 9:47 pm

    TUESDAY, Dec. 9, 2025 -- Socioeconomic vulnerability and multiple medical comorbidities are risk factors for late-onset depression among long-term cancer survivors, according to a study published online Nov. 26 in JAMA Network Open.Melissa Taylor...

  • Downstream Harms of Gabapentinoid-Diuretic Prescribing Cascade Often Overlooked
    on 09/12/2025 at 9:39 pm

    TUESDAY, Dec. 9, 2025 -- The potential downstream harms in the gabapentinoid (gabapentin and pregabalin)-edema-loop diuretic (LD) prescribing cascade are commonly overlooked, according to a study published online Dec. 2 in JAMA Network Open.Matthew...

  • AI-Based Ambient Scribes May Reduce Physician Documentation Time, Burnout
    on 09/12/2025 at 9:36 pm

    TUESDAY, Dec. 9, 2025 -- Artificial intelligence (AI)-based ambient scribes may reduce documentation time and improve physician well-being, according to a study published online Nov. 26 in NEJM AI.Paul J. Lukac, M.D., from the University of...

  • FDA Approves Expanded Indication for Jaypirca
    on 09/12/2025 at 9:31 pm

    TUESDAY, Dec. 9, 2025 -- The U.S. Food and Drug Administration has approved an expanded indication for Jaypirca (pirtobrutinib), the first and only noncovalent Bruton tyrosine kinase (BTK) inhibitor for adults with relapsed or refractory chronic...

  • Prepregnancy Eating Disorders Linked to Wheezing, Asthma in Offspring
    on 09/12/2025 at 4:12 pm

    TUESDAY, Dec. 9, 2025 -- Prepregnancy eating disorders (EDs) are associated with an increased risk for preschool wheezing and school-aged asthma in offspring, according to a study published online Dec. 2 in Thorax. Maja Popovic, Ph.D., from the...

  • ASH: Agent Orange Exposure Linked to Increased Risk for Myelodysplastic Syndrome
    on 09/12/2025 at 4:12 pm

    TUESDAY, Dec. 9, 2025 -- Agent orange (AO) exposure is associated with an increased risk for myelodysplastic syndrome (MDS), according to a study presented at the annual meeting of the American Society of Hematology, held from Dec. 6 to 9 in...

  • ASH: No Specific Harms Found for Hydroxyurea Use During Pregnancy
    on 09/12/2025 at 4:12 pm

    TUESDAY, Dec. 9, 2025 -- There is no clear evidence of harm for women receiving hydroxyurea (HU) during pregnancy for sickle cell disease, according to a study presented at the annual meeting of the American Society of Hematology, held from Dec. 6...

  • ASH: Lifestyle Intervention Feasible During Chemo for Lymphoma
    on 09/12/2025 at 4:12 pm

    TUESDAY, Dec. 9, 2025 -- A lifestyle intervention is feasible for patients with lymphoma undergoing chemotherapy, according to a study presented at the annual meeting of the American Society of Hematology, held from Dec. 6 to 9 in Orlando...

  • AES: Antiseizure Medication Failure Elevated for Those With Epilepsy, Depression
    on 09/12/2025 at 4:12 pm

    TUESDAY, Dec. 9, 2025 -- People with newly diagnosed epilepsy and a diagnosis of depression are more likely to fail their first antiseizure medication, and people with depression have an increased risk of being diagnosed with epilepsy at a later...

Theme by Out the Box
  • News
  • Blog Zone
  • Contact